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Detection of people at risk of developing
a ﬁrst psychosis: comparison of two
recruitment strategies
Rietdijk J, Klaassen R, Ising H, Dragt S, Nieman DH, van de Kamp J,
Cuijpers P, Linszen D, van der Gaag M. Detection of people at risk of
developing a ﬁrst psychosis: comparison of two recruitment strategies.
Objective: Better recruitment strategies are needed to improve the
identiﬁcation of people at ultra-high risk of developing psychosis. This
study explores the eﬀectiveness of two recruitment strategies: a
screening method in a consecutive help-seeking population entering
secondary mental health services for non-psychotic problems vs. a
population referred to the diagnostic center of an early-psychosis
clinic.
Method: From February 2008 to February 2010, all general
practitioner and self-referrals (aged 18–35 years) to the secondary
mental healthcare service in The Hague and Zoetermeer were screened
with the Prodromal Questionnaire; patients who scored above the
cutoﬀ of 18 and had a decline in social functioning were assessed using
the Comprehensive Assessment of At-Risk Mental States (CAARMS).
All referrals (aged 14–35 years) to the diagnostic center in Amsterdam
were also assessed with the CAARMS.
Results: The screening detected a three-fold higher prevalence of
at-risk mental states: these subjects were older and more often female.
manova showed signiﬁcantly higher scores for the screened population
on depression, social anxiety, distress with positive symptoms, and a
higher rate of transition to psychosis within 12 months.
Conclusion: The screening method detects more patients with at-risk
mental states than the referral method. The latter method is biased to
young male patients in an earlier prodromal stage and a lower
transition rate.
J. Rietdijk1,2, R. Klaassen3,
H. Ising1,2, S. Dragt4,
D. H. Nieman4, J. van de Kamp1,2,
P. Cuijpers1, D. Linszen4,
M. van der Gaag1,2
1Department of Clinical Psychology, VU University
Amsterdam and EMGO+ Institute for Health and Care
Research, Amsterdam, the Netherlands, 2Department of
Psychosis Research, Parnassia Psychiatric Institute, The
Hague, the Netherlands, 3GGz Rivierduinen, Department
of Children and Adolescent Care, Leiden, the
Netherlands and 4Department of Early Psychosis,
Academic Medical Center, University of Amsterdam,
Amsterdam, the Netherlands
Key words: early detection; at-risk mental states;
ultra-high-risk screening; psychosis
Judith Rietdijk, Department of Clinical Psychology, VU
University Amsterdam and EMGO+ Institute for Health
and Care Research, Amsterdam, the Netherlands.
E-mail: judithrietdijk@gmail.com
Accepted for publication January 16, 2012
Significant outcomes
• Screening detected more patients with at-risk mental states or psychosis at the gate of the mental
health services than did referral.
• Screening did not lead to an increase in the number of false-positive cases, as demonstrated by the
higher transition rates in the screened population compared to the referred population.
• In the at-risk mental state stage, both sexes showed similar subclinical psychotic symptom proﬁles;
however, women showed more anxiety and depression symptoms.
Limitations
• The detection methods were not assigned to the mental healthcare service at random.
• The two recruitment populations differed in age: screening was conducted in patients from age
18–35 years whereas the referred group was aged 14–35 years.
• Because the transition rate in the referred group was low, differences in diagnoses after psychosis
onset could not be analyzed.
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Introduction
Most psychotic disorders are preceded by a
prodromal phase. This phase, prospectively called
the at-risk mental state (ARMS) phase, is a
potential target for intervention to prevent or
delay the onset of psychosis, or to improve the
outcome by reducing the duration of untreated
psychosis. It has been debated whether this ARMS
phase should be added as an additional diagnosis
in the DSM-V, called the attenuated psychosis
syndrome (1). One of the counter arguments to the
use of the ARMS is the declining transition rates to
psychosis in ultra-high-risk (UHR) studies (2). In
the earliest UHR studies, transition rates to
psychosis were about 40% within 1 year (3, 4).
Since then, UHR studies have reported declining
transition rates of 7–16% within 2 years (5).
Moreover, the proposed diagnosis has only been
applied in research settings that attract ill individ-
uals at rates disproportionate to those occurring in
the overall population. It is unclear whether ﬁeld
tests away from these settings will result in the
same conversion rates to psychosis. One of the
main challenges in establishing the reliability and
validity of ARMS is the recruitment of an ade-
quate ARMS sample size, and limiting the number
of false-positive cases (6).
Epidemiological studies in the general popula-
tion have identiﬁed risk and environmental fac-
tors preceding the onset of psychotic disorders,
that is, subclinical psychotic symptoms before the
ﬁrst episode (7, 8). However, screening methods in
the general population revealed that these
subclinical symptoms were highly prevalent and
non-speciﬁc, so that an excess of false-positive
individual cases were found to be at risk of
psychosis (9–12).
Screening methods for detecting ARMS have
been explored using a variety of populations. The
ﬁrst prospective early detection and intervention
study was conducted by Falloon et al. (13), who
trained general practitioners (GPs) in detecting early
signs of schizophrenia. Later studies screened help-
seeking persons in a primary care setting (14) or
students in a general college population (15). How-
ever, high false-positive rates remained a problem.
Nowadays, ARMS is determined by a combina-
tion of risk factors, including genetic susceptibility
as well as symptomatology (16). For example, the
presence of two or more subclinical psychotic
symptoms in a speciﬁc age group (14–35 years) of
patients referred to a specialized clinic in combi-
nation with a depressed mood results in a 40%
chance of developing a psychosis within 2 years
(12). The reduction in false-positive cases reached
by combining risk factors is accompanied by the
disadvantage of ﬁnding more false-negative cases
in the subsample that does not meet all the risk
criteria.
The current case recruitment strategy of ARMS
individuals in early-psychosis research relies on
referral at suspicion of a psychotic development to
a tertiary medical center, because performing the
earlier screening methods in a general population
resulted in too many false-positives. Studies using
this method reported a mean annual recruitment of
18 ARMS cases per year per institute (17). For
instance, McGlashan et al. (18) needed 4 years to
recruit 60 ARMS patients by referral in a recruit-
ment area with an expected yearly prodromal
incidence rate of 600 persons. The prepsychotic
symptoms are mostly subtle and not recognized as
subclinical in the general mental health care (19);
this could explain why many cases are missed when
employing this strategy.
Sequential screening, ﬁrst proposed by Bell
(16), may oﬀer a solution to both the false-
positives and the missed cases. Sequential screen-
ing in detecting emerging psychosis involves the
combination of a number of diﬀerent risk factors
(age, help seeking, social decline, genetic risk)
and screening measures (interviews and question-
naires). A sample becomes more enriched with
psychosis-prone subjects when it has passed
through more mental health ﬁlters (10). That is
why high proportions of people with psychosis or
ARMS are found in those referred to tertiary
specialized clinics. Most people who develop a
psychotic disorder sought help in the secondary
mental health services for non-psychotic mental
disorders prior to the onset of psychosis (20).
Screening in a consecutive help-seeking popula-
tion may detect prodromal patients more eﬃ-
ciently. Therefore, the Dutch Early Detection
and Intervention Evaluation (EDIE-NL) used a
two-stage screening strategy in the complete
help-seeking population (aged 18–35 years) in
one site and the traditional referral method
(aged 14–35 years) in another site (21). This
oﬀers the opportunity to explore diﬀerences
between the screened and referred populations.
A sample in a secondary mental health service
has one ﬁlter less than a sample in a tertiary
clinic, and we expect more false-positive cases
using the Comprehensive Assessment of At-Risk
Mental States (CAARMS) (3) in the less psy-
chosis-prone secondary mental health service
sample, even after prescreening with the Prodro-
mal Questionnaire (PQ) (22).
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Aims of the study
The present study examines similarities and
diﬀerences in the ultra-high-risk population col-
lected by screening, compared to the ultra-high-
risk population collected by referral. We expect to
ﬁnd more false positives in the consecutive help-
seeking population. We also expect to ﬁnd more
women with at-risk mental states, as more women
seek help in the secondary mental health services
(23).
Material and methods
This study analyzed data from the EDIE-NL
study, which is a longitudinal randomized con-
trolled trial comparing treatment as usual (TAU)
with an add-on cognitive behavioral therapy (CBT)
targeted at the prevention of psychosis. A compre-
hensive description of the study, aims, sample
procedure, diagnostic instruments, randomization
protocol, quality control procedures and analysis
has been documented elsewhere (21).
The study was approved by the Dutch Union of
Medical-Ethics Trial Committees for mental
health organizations and was conducted in
compliance with the Declaration of Helsinki
(amendment of Edinburgh, 2000). The trial is
registered at Current Controlled trials as trial
number ISRCTN21353122.
Informed consent was given after the procedure
had been fully explained. Informed consent was
also obtained from parents or guardians if the
participant was aged £ 18 years.
Setting and recruitment
The screening method was implemented in the
secondary mental healthcare service PsyQ Haa-
glanden, which is the provider of secondary general
adult mental health care for The Hague (±488 000
inhabitants) and Zoetermeer (±120 000 inhabit-
ants). Help-seeking individuals, referred by their
GPs or self-referred, were ﬁrst interviewed by
telephone and preselected for further assessment
and diagnosis at a speciﬁc care program (e.g.,
anxiety disorders, depression, attention deﬁcit
hyperactivity disorder (ADHD), and six additional
conditions). If people were aged 18–35 years old,
they received the PQ (22)) by post. Participants
were asked to ﬁll in the questionnaire and to bring
the PQ to the assessment and diagnosis appoint-
ment at the speciﬁc care program. If people scored
positive on 18 or more of the 45 subclinical positive
psychotic symptoms of the PQ, they were inter-
viewed with the CAARMS (3).
Between February 2008 and February 2010, all
3671 consecutive help-seeking persons (in the age
range 18–35) were prescreened with the PQ. Of
these, 420 patients were interviewed with the
CAARMS.
The referral recruitment method was practiced
in the tertiary early-psychosis service of the
Academic Medical Center in Amsterdam
(±770 000 inhabitants). Patients were referred
for a second opinion by psychiatrists, psycholo-
gists, GPs, outreach services, counseling services
and schoolteachers, or the help seeking was
initiated by the patient or their family. Between
February 2008 and February 2010, 193 referrals in
the age range 14–35 were assessed for an at-risk
mental state of developing psychosis with the
CAARMS. About 50% of these referrals origi-
nated from the city of Amsterdam; the remainder
came from smaller towns and villages in the
surrounding area.
Sample
The ARMS groups consists of three subgroups
(3, 24): i) patients with a schizotypal personality
disorder or a ﬁrst-degree relative with psychosis; ii)
patients experiencing attenuated positive symp-
toms, such as ideas of reference, odd beliefs,
magical thinking or unusual perceptual experi-
ences; and iii) patients who had experienced a brief
psychotic episode of £1 week duration that
resolved without antipsychotic medication (i.e.,
brief limited intermittent psychotic symptoms;
BLIPS).
In addition, ARMS patients had to fulﬁll the
criterion of impaired social functioning as assessed
with the Social and Occupational Functional
Assessment Scale (SOFAS (25), which means a
SOFAS score of £55 and ⁄or a drop in the SOFAS
score of 30%.
Exclusion criteria were as follows: i) current or
previous usage of a cumulative dose of antipsy-
chotic medication of (in total) ‡ 15 mg haloperidol
equivalent (e.g., maximum of 5 days of 3 mg); ii)
severe learning impairment; iii) problems arising
from an organic condition; iv) insuﬃcient compe-
tence with the Dutch language; and v) history of
psychosis.
Instruments
After signing informed consent, the baseline
assessments were performed. Patients were then
interviewed with the CAARMS after 2, 3, 6, 9, 12,
15, and 18 months. We report here on the
12-month results.
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A comprehensive description of the instruments
used in this study can be found elsewhere (21).
i) The Prodromal Questionnaire (22) (PQ;
authorized Dutch translation by van der
Gaag, Klaassen, and Wunderink and called
the Experiences List) is a 92-item self-report-
ing questionnaire that assesses the presence of
lifetime prodromal symptoms. Of these items,
45 refer to positive psychotic symptoms.
A pilot study showed that a cutoﬀ score of
18 resulted in a psychosis-prone enriched
sample comprising about 15% of the
help-seeking population.
ii) The Comprehensive Assessment of At-Risk
Mental States (CAARMS) (3), including
SOFAS (25), is a semi-structured interview
conducted to determine the presence, severity,
frequency, and type of ARMS symptoms. The
EDIE-NL researchers received an extensive
2-day training from Dr. Alison Yung (one of
the developers of the CAARMS). During the
study period, reliability checks of the Dutch
version of the CAARMS were performed
about every 3 months. The pairwise inter-
rater concordance of the CAARMS was 0.97
and was considered acceptable by the training
team.
iii) Semantic verbal ﬂuency is assessed with a
subtest of the Groninger Intelligence Test.
During a 60-second period, patients are asked
to recall various animal names (26).
iv) Depression is assessed with the Dutch trans-
lation of the Beck Depression Inventory
second edition (BDI-II-NL)(27).
v) The Calgary Depression Scale (CDS) is a
9-item interview that assesses depressive symp-
toms independent of the negative symptoms of
schizophrenia (28).
vi) The Social Interaction Anxiety Scale (SIAS) is
a 20-item self-report questionnaire measuring
social anxiety (29).
vii) The Personal Beliefs about Illness Question-
naire-Revised (PBIQ-R) is a self-rating ques-
tionnaire that assesses the subjective appraisal
of the illness (30).
viii) The Dutch version of the Schedules for
Clinical Assessment in Neuropsychiatry
(SCAN 2.1) was used to assess the DSM
IV-diagnosis after transition to psychosis
(31).
ix) The demographic questionnaire is a measure
developed by the researchers to assess demo-
graphic characteristics, based on previous
research and known risk factors for psychotic
disorders.
Measurement of transition
The primary outcome measure is the transition to
psychosis, as deﬁned by the CAARMS criteria, or
the start of using antipsychotic medication and a
conﬁrmation of the psychotic state by the
CAARMS. After transition into psychosis, diag-
noses were assessed with the SCAN 2.1 (31).
Statistical analyses
Group diﬀerences were explored using the Statis-
tical Package for the Social Sciences (SPSS 18.0
Statistics, UK) for Windows. Comparison of
baseline characteristics (age, level of education,
sex, inclusion group, marital status, living situa-
tion, urban environment, bullying in the past and
undesired pregnancy mother, school attendance,
hand preference, ethnic identity, and drug use in
the last year) between the screened sample and
the referred sample was made with Pearsons
two-tailed chi-square tests and independent
sample t-tests.
Multivariate analyses of variance (manova) were
conducted to assess diﬀerences in baseline symp-
tomatology, such as CAARMS symptoms, distress
with positive symptoms, depressive mood, and
anxiety.
Univariate analysis of variance (anova) and
chi-squares were performed on the 12-month
follow-up transition rate.
Results
Demographic characteristics
The screening method found 52 psychotic patients
and 147 patients at risk in a recruitment area of
608 000 people (prevalence ARMS: 0.024); 93
ARMS patients signed informed consent. In
total, 193 patients were referred to the diagnostic
center of the early-psychosis clinic in a recruitment
area of at least 770 000 inhabitants; of these, 66
patients had full-blown psychotic symptoms, 66
subjects had an at-risk mental state (prevalence
ARMS: 0.008), and 61 patients did not meet the
ARMS or psychosis criteria; 40 ARMS patients
signed informed consent. Most of those who did
not sign informed consent were unwilling to do the
additional testing during the study and ⁄or to
adhere to the additional intervention, apart from
the disorder for which they originally sought help,
or they dropped out of routine care.
A two-tailed independent samples t-test was
performed to explore diﬀerences in age between
the twopopulations in the study. People recruited by
Rietdijk et al.
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screening were signiﬁcantly older (mean = 25.5,
SE = 0.51) than the referred subjects (mean=20.6,
SE = 0.68); (t (131) = 4.19, P = 0.043). No dif-
ferences were found for mean years of education
between the screened population (mean = 13.9, SE
=0.27)and the referredpopulation (mean = 13.60,
SE = 0.38); t (127) = 0.61, P= 0.55.
Table 1 presents data on the two-tailed Pearsons
chi-square tests for several other demographic
characteristics of the patients in both groups. The
distribution of the subgroups within the ARMS
group is remarkably similar in both recruitment
strategies. There were signiﬁcantly more women
thanmen in the screened population.Most people in
the screened population lived with their partner
and ⁄or children, whereas most patients in the
referred population lived with their parents.
Subjects in the screened population reported more
bullying during their childhood, and their mothers
more often reported that the pregnancy had been
undesired. Most of the referred subjects were still
studying. After correction for age and sex, signiﬁ-
cant diﬀerences remained for marital status (F (3,
129) = 18.02, P < 0.0001) and currently studying
(F (3, 129) = 4.97, P < 0.0001).
Psychopathology
After meeting the criteria for the assumptions of
parametric tests, two-tailed multivariate Analysis
of Covariance (mancova) was performed to explore
the diﬀerences in psychopathology between the
screened and the referred population (Table 2).
The analysis was corrected for age, sex, and the
interaction eﬀect site*sex, because the age and
gender proﬁle diﬀered signiﬁcantly between both
Table 1. demographic characteristics for ARMS patients in screened and referred recruitment groups
Screened Referred
N = 93 Percent N = 40 Percent X2 df P
Sex
Female 60 64.5 6 15.0 27.43 1 <0.0001
Inclusion group
Genetic risk 16 17.2 7 17.1 0.49 3 0.92
Attenuated symptom 76 81.7 33 80.5
BLIPS 1 1.1 0 0
Marital status
Married 34 36.6 2 5.0 20.48 2 <0.0001
Never married 51 54.8 38 95.0
Divorced 8 8.6 0 0.0
Living situation
Living independently 15 16.5 7 17.5 36.90 5 <0.0001
With parents 24 25.8 30 75
With partner and ⁄ or children 44 47.3 1 2.5
Residential 1 1.1 0 0
Other 7 7.5 2 5.0
Missing 2 2.1 0 0
Urban environment
<10.000 0 0 3 7.5 100.9 4 <0.0001
10.00–100.000 13 14.0 14 35.0
100.000–250.000 8 8.6 0 0.0
250.000–500.000 72 77.4 0 0.0
>500.00 0 0.0 23 57.5
Still in school
Yes 20 21.7 15 38.5 3.91 1 0.048
Has a paid job
Yes 51 56.0 14 35.9 11.13 6 0.084
Undesired pregnancy mother
Yes 23 24.7 7 17.5 15.23 2 <0.0001
Breast feeding
Yes 63 70.8 17 60.9 2.01 1 0.37
Bullied in past
Yes 61 67.0 15 38.5 10.67 1 0.005
Hand preference
Right handed 85 92.4 32 82.1 3.07 1 0.078
Ethnic minority
Yes 52 55.9 19 47.5 0.80 1 0.372
Drug use last 12 months
Yes 29 31.5 15 39.5 0.76 1 0.38
BLIPS, Brief limited intermittent psychotic symptoms.
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groups. The screened population scored signiﬁ-
cantly higher than the referred population on the
Beck Depression Inventory scale, the Calgary
depression scale, the Social Interaction Anxiety
Scale, the Personal Beliefs about Illness Question-
naire, and on distress (CAARMS) and total
general psychopathology (CAARMS). mancova
showed that these diﬀerences were signiﬁcantly
inﬂuenced by site (F (7) = 2.68, P = 0.013) and
age (F (7) = 4.58, P < 0.0001), but not by sex
(F (7) = 0.282, P = 0.96) or the interaction
site*sex (F (7) = 0.73, P = 0.643).
Transition to psychosis
A transition is deﬁned by the CAARMS criteria or
the start of using antipsychotic medication and a
conﬁrmation of the psychotic state by the
CAARMS. At 12 months, 78 patients were in the
screening condition (attrition 16%) and 32 in the
referred condition (attrition 20%). In the screened
population, 21 ARMS patients made the transition
to psychosis vs. 3 ARMS patients in the referred
population. This diﬀerence is signiﬁcant (X2(1,
n = 110) = 4.1, P = 0.043. There were no diﬀer-
ences in the transition rates between the sexes. It
was not possible to explore diﬀerences in transition
diagnoses, as the transition rate in the referred
population was too low.
Discussion
The current study is the ﬁrst to explore the
diﬀerences in samples of patients at ultra-high
risk of developing psychosis recruited by screening
in a secondary mental health service compared to a
sample that was referred to the diagnostic center of
a tertiary specialized clinic for early psychosis. The
results are not conclusive, but are necessarily
preliminary as the institutes were not randomly
assigned to one of the recruitment conditions.
The results show at least a three-fold higher
proportion per capita of at-risk mental states in the
screened population compared to the referred
group. As in this calculation, we only included
the number of inhabitants of Amsterdam city and
excluded the number of inhabitants of the sur-
rounding towns ⁄villages; the ratio is in fact even
more in favor of screening. Compared with the
referred sample, the screened patients diﬀered on
demographic characteristics and psychopathology.
On average, the screened sample was older, more
often female, more often married and employed. In
terms of psychopathology, the screened population
showed more symptoms, such as depression, anx-
iety, and more distress from their subclinical
positive psychotic symptoms. On the other hand,
they did not report more subclinical psychotic
symptoms. Comparison between the referred pop-
ulation and referred populations in previous
ARMS studies reveals a similar proportion of
detected ARMS patients per institute, that is, 18
patients per institute per year (17). The predomi-
nantly young male population in the referral
condition is also similar.
At 12-month follow-up, the screened population
showed more transitions to psychosis than the
referred population (22.5% vs. 7.5%, respectively).
The low rate in the referred population was also
reported in other studies (5). This might be due to
Table 2 Psychopathology (corrected for age, sex, and site*sex) for both recruitment ARMS groups using mancova
Screened
N = 93
Estimated mean (SE)
Referred N = 40
Estimated mean (SE) F df P
SOFAS 46.83 (0.560) 45.69 (1.24) 0.673 1 0.414
Depression BDI 28.78 (1.15) 15.71 (2.53) 14.56 1 <0.0001
Calgary depression scale 7.16 (0.48) 3.37 (1.07) 10.03 1 0.002
Sias 35.88 (1.74) 24.11 (3.84) 7.48 1 0.007
PBIQ 77.51 (1.52) 68.80 (3.37) 5.33 1 0.023
MANSA 49.15 (1.31) 55.89 (2.91) 4.28 1 0.041
Word fluency 20.94 (0.64) 21.41 (1.40) 0.087 1 0.77
CAARMS
Total positive symptoms 10.73 (0.31) 9.85 (0.69) 1.284 1 0.26
Total distress 192.33 (8.13) 146.69 (17.97) 5.14 1 0.025
Total cognitive changes 3.33 (0.18) 3.36 (0.40) 0.004 1 0.95
Total emotional disturbance 4.02 (0.24) 3.49 (0.54) 0.77 1 0.38
Total negative symptoms 7.96 (0.31) 6.73 (0.68) 2.59 1 0.11
Total behavioral changes 9.84 (0.35) 8.49 (0.78) 2.40 1 0.12
Total motor changes 4.82 (0.34) 3.41 (0.74) 2.89 1 0.092
Total general psychopathology 16.58 (0.55) 13.85 (1.22) 3.95 1 0.049
SOFAS, Social and occupational functioning assessment scale; BDI, Beck depression inventory; CDS, Calgary depression scale; SIAS, social interactions anxiety scale; PBIQ,
personal beliefs about illness questionnaire; MANSA, Manchester short assessment of quality of life; CAARMS, comprehensive assessment of at-risk mental states.
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the additional risk factor help-seeking for mental
problems in the screened population (12). For
instance, a higher rate for depression is associated
with the late prodromal stage of psychosis, which is
in line with the higher depression scores for the
screened population (32, 33). We believe that the
arguments for the decline of transition rates in
referral samples owing to better awareness are not
applicable to the screened population (2).
These ﬁndings, in particular the higher propor-
tion of the at-risk mental state and the higher
transition rate in the screened population, suggest
that screening a help-seeking population entering
the secondary mental health services for non-
psychotic problems detects patients who are in a
late prodromal stage. Community health caretak-
ers do not routinely assess subclinical psychotic
symptoms. As a result, many of these patients
might have been overlooked using the traditional
referral process to the specialized clinical research
settings. This is supported by the detection of 52
psychotic patients in the screened population, who
were not diagnosed as such. In addition, the
referral group showed 66 subjects already suﬀering
from a psychosis while they were referred for
at-risk mental states. The latter result is in line with
previous studies reporting a seven times longer
duration of untreated psychosis in patients who
were treated in the secondary mental health care
for non-psychotic disorders (34, 35) and in patients
visiting GPs for psychological problems (19).
The screened population included more women,
in contrast to referral studies on the early detection
of high-risk groups. This is not surprising, as
women seek help more often for other psychiatric
problems (20, 23), and two-third of the complete
screened help-seeking population was female. In
the model of Van Os et al. (8), women with a
psychosis started more often with positive and
aﬀective symptoms, social conﬂict and help-seek-
ing behavior compared to men who suﬀer more
from cognitive and negative symptoms and tend to
socially withdraw.
The observed predominance of women may also
be explained by the scope of the detection methods.
On the one hand, the screening strategy was
successful in covering a broader range of psycho-
ses, namely where psychotic symptoms and aﬀec-
tive symptoms overlap. The screening method
included mood disorders with psychotic features
and bipolar disorders, which are also associated
with women (36, 37). On the other hand, subjects
in the referred sample were mostly referred based
on suspicion for developing a schizophrenic psy-
chosis. Therefore, it is expected that the referred
group will show more negative symptoms as well as
social decline compared to the screened sample.
Contrary to our expectations, both groups showed
comparable levels of negative symptoms.
Detection of the large percentage of women
raises the question as to whether screening detects
a diﬀerent (older female) group of high-risk
patients. However, the results show that the
diﬀerences in subclinical positive and negative
symptoms, as well as psychopathology, in the
ARMS stage were generated by site and age; no
eﬀect was found for sex. Thus, it appears that both
men and women reported the same degree of
subclinical psychotic symptoms. This is in line with
previous research, which suggests that females fell
ill 3–4 years later, but that sex had no substantial
impact on the core symptoms of schizophrenia
(38). Nonetheless, Lewine found diﬀerences in the
premorbid functioning in men and women (39).
However, it is not clear whether these diﬀerences
are the result of age and sex being confounders.
Schizophrenia might be the same disorder in the
two sexes, but has an early onset in men and is thus
associated with typical schizophrenic symptoms
and poor premorbid functioning.
In the present study, the diﬀerence in age
between the two locations is partly the result of
the selected age range of the recruitment popula-
tion. The tertiary psychosis clinic recruits patients
aged 14 years and older, whereas the screening was
implemented in PsyQ Haaglanden, which provides
care for adults only (aged ‡ 18 years). The mean
age for having an at-risk mental state, and the
mean age at psychosis onset, varies between studies
conducted in diﬀerent populations. Recruitment in
an adolescent population results in the ﬁnding of a
young ARMS cohort, with a mean age of 19 years
(40, 41). Clinical trials in adult cohorts reported an
average age of 25 years (42) and 26 years (43).
Ha¨fner et al. even found a mean psychosis onset
age of 29 years (38). This supports our suggestion
that referral and research on high-risk patients and
ﬁrst-episode patients is biased toward young
patients.
Clinical implications
Patient recruitment of the current early-psychosis
studies depends on signaling a psychotic or schizo-
phrenic development by referrers. However, the
screening method in the present study detected
more patients with an at-risk mental state of
developing psychosis. This suggests that many
psychotic developments are missed by untrained
community health caretakers, who are the most
important referrers to the specialized clinical
research centers. Screening will most probably
Detection of people at risk of developing a ﬁrst psychosis
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lead to the early detection of females and older
patients who are often overlooked because of a
bias favoring young males in detecting psychosis.
The screened sample had a higher transition rate
than the referred sample; this strongly suggests that
screening did not lead to more false-positive cases.
The screening method detects more patients at
the gate of the mental health services and prevents
under-diagnosis and under-treatment. In our opin-
ion, screening does not provide an avenue toward
the early detection of the genetic group (one of the
three groups described as being at risk), as they do
not necessarily have subclinical psychotic symp-
toms. Neither does it lead to an early detection of
patients who have been in care for a longer period
before the onset of psychotic symptoms, as the
screening is only conducted at initial assessment.
Nevertheless, we believe that screening, as well as
referral options, should play a more prominent
part in the general secondary mental health care.
Despite the advantages of the screening method,
some disadvantages also exist. The most important
concerns the greater amount of staﬀ time required
as a result of a lower speciﬁcity compared to a
referral strategy. Of the 420 PQ positives, 52 (12%)
were diagnosed as being psychotic and 147 (35%)
were diagnosed with ARMS with the CAARMS.
This means a total PQ true-positive rate of 47%
and a false-positive rate of 53%. Similarly, the 193
referred patients yielded a total true-positive rate
of 68% and a false-positive rate of 32%. As a
result, the screening method required more inter-
view time. The burden on the patient is that they
had to complete the PQ and a CAARMS interview
taking (on average) about 1 h.
In addition, the higher false-positive rate could
lead to stigmatizing patients who were, with
hindsight, not at ultra-high risk of developing
psychosis. However, to prevent stigma in people
with ARMS, they were informed that the criteria
were for a risk proﬁle to develop future psychiatric
problems (without mentioning psychosis) and that
it might be possible to prevent these future
problems with an add-on intervention. Oﬀering
help was not stigmatizing, as these people were in
fact seeking help from the start.
Strengths and limitations
The study has several strengths and limitations.
The main limitation is that, because this is an
explorative study, the two recruitment strategies
were not assigned at random to the sites; therefore,
the results should be interpreted with caution.
A randomized controlled trial testing the detection
methods will provide a more comprehensive test of
the potential contribution of screening in second-
ary mental healthcare services in the early detection
of psychosis.
A second limitation is the small sample size of
the referred population. Nevertheless, the charac-
teristics of the referred sample are in line with other
tertiary specialized early-psychosis departments.
A third limitation is the use of the self-report
questionnaires, such as the Beck Depression Inven-
tory and the Social Interaction Anxiety Scale. This
may distort the ﬁndings by introducing report
biases, such as over- or under-reporting of symp-
toms. Again, caution is therefore required in
interpreting the outcomes. On the other hand, we
emphasize that the Calgary Depression Scale and
the CAARMS interviews that were conducted by
trained psychologists show the same results as the
self-report questionnaires. This indicates that the
subjects made a reliable report of their symptoms
on the self-report questionnaires.
A fourth limitation concerns the study popula-
tions. The screening method was conducted in
patients aged 18–35 years, whereas the age group
of the referred group was 14–35 years. This might
explain the diﬀerences in mean age, marital status,
and living situation, apart from the sex diﬀerences.
The screening method missed the UHR adoles-
cents, as PsyQ Haaglanden only provides care for
patients aged ‡ 18 years. Therefore, it is not pos-
sible to explore and compare the exact prevalence
of help-seeking patients at risk of psychosis.
However, if the age range of the screened popula-
tion was as large as for the referred population
(14–35 years), the numbers may have given an even
clearer indication in favor of the screening method,
as the screening would also detect the UHR
adolescents in addition to the UHR adults.
A ﬁfth limitation is that the patients were
followed up for only 12 months; patients in the
earlier prodromal stage in the referred condition
probably had such a low transition rate because
they need more time to develop frank psychosis.
The lower transition rate in the referred group
might be the result of the detection of an at-risk
mental state in a much earlier stage than detected
by screening. A follow-up period longer than
1 year is required to test this hypothesis.
The ﬁnal limitation is that the transition rates
are possibly aﬀected by the treatment oﬀered to a
part of the ARMS group. Subjects in both the
referred and the screened population were ran-
domly assigned to a treatment-as-usual group and
to a group receiving a treatment-as-usual with an
add-on cognitive behavioral therapy targeting the
high-risk symptoms. Thus, transition rates might
be lower than those in naturalistic studies, as the
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intervention aimed to reduce the number of tran-
sitions to a ﬁrst-episode psychosis. Second, the
transition rate in the referred group was low; this
resulted in a deﬁciency in analyzing diﬀerences in
psychotic onset diagnoses between the two recruit-
ment strategies.
A major strength of this study is the fact that the
screened population consisted of a representative
sample of all consecutively help-seeking patients in
a well-described region, and that this sample was
compared to a referred population.
A further strength is that the study has strong
internal and external validity. The early detection
of psychosis was implemented in routine care in
both services. This has an immediate and positive
eﬀect on clinical practice. All raters who inter-
viewed the patients in the diﬀerent institutes were
trained by Dr. A Yung and were given ﬁdelity
checks every 3 months.
We conclude that screening for psychotic
symptoms in a help-seeking population aged
18–35 years leads to detection of an ARMS
group that is comparable on subclinical psychotic
symptoms to the ARMS group in a referred
population. The higher transition rate, higher
age, and the higher levels of depression, anxiety,
and distress in the screened group might indicate a
later prodromal stage in the ARMS group than
when people are at-risk and are referred to a
tertiary specialized clinic. The larger proportion of
female ARMS patients in the screening recruitment
strategy might reﬂect the fact that, compared to
men, women more often seek help in secondary
mental health care.
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